
The company’s R&D and commercial expertise represent valuable capabilities for future Chinese partners
Boost efficiency in clinical operations! Learn a creative way to enhance communication between teams at different sites and streamline the development of study protocols, support materials, and journal submissions.

The funds will go towards a new global research and development centre in Beijing’s BioPark

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.

Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.

Sanofi will make an initial equity investment of €300m in Innovent

Danish diabetes specialist Novo Nordisk cuts its growth forecast for 2022 following a value-based procurement deal with the Chinese government for its insulin products

Vaccine found to be 79% effective in top-line results

Safety data was published on pre-print server medRxiv
Tom Hsu, VP of Specialty Medicine at Bayer Canada, talks about how he got to where he is today and his experience working for Bayer in China, and how that compares to...

China secures a place at the forefront of innovative medicine